Article (Scientific journals)
New rationales for using TGFbeta inhibitors in radiotherapy.
Andarawewa, Kumari L.; Paupert, Jenny; Pal, Anupama et al.
2007In International Journal of Radiation Biology, 83 (11-12), p. 803-11
Peer Reviewed verified by ORBi
 

Files


Full Text
paupert int j radiat biol.pdf
Publisher postprint (264.94 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins/metabolism; DNA Damage; DNA-Binding Proteins/metabolism; Humans; Models, Biological; Neoplasms/drug therapy/genetics/metabolism/radiotherapy; Radiation Tolerance/drug effects/physiology; Radiobiology; Signal Transduction/drug effects/physiology/radiation effects; Transforming Growth Factor beta/antagonists & inhibitors/metabolism; Tumor Suppressor Proteins/antagonists & inhibitors/metabolism
Abstract :
[en] PURPOSE: The first reports that ionizing radiation (IR) induces rapid and persistent activation of transforming growth factor beta1 (TGFbeta) were nearly two decades ago. Subsequent studies have shown that TGFbeta is a major mediator of cellular and tissue responses to IR and have revealed novel facets of its complex biology. RESULTS: We and others have recently shown that inhibition of production or signaling of TGFbeta in epithelial cells modulates radiosensitivity and impedes activation of the DNA damage response program. The primary transducer of cellular response to DNA damage caused by ionizing radiation is the nuclear protein kinase ataxia telangiectasia mutated, whose activity is severely compromised when TGFbeta is inhibited. Thus, in conjunction, with its well-recognized contribution to normal tissue fibrosis, the role of TGFbeta in the genotoxic stress program provides a previously unsuspected avenue to modulate radiotherapy. CONCLUSIONS: We hypothesize that identification of the circumstances and tumors in which TGFbeta manipulation enhances tumor cell radiosensitivity, while protecting normal tissues, could significantly increase therapeutic index.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Andarawewa, Kumari L.
Paupert, Jenny ;  Lawrence Berkeley National Laboratory
Pal, Anupama
Barcellos-Hoff, Mary Helen
Language :
English
Title :
New rationales for using TGFbeta inhibitors in radiotherapy.
Publication date :
2007
Journal title :
International Journal of Radiation Biology
ISSN :
0955-3002
eISSN :
1362-3095
Publisher :
Taylor & Francis, United Kingdom
Volume :
83
Issue :
11-12
Pages :
803-11
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 06 January 2014

Statistics


Number of views
43 (0 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
59
Scopus citations®
without self-citations
55
OpenCitations
 
58

Bibliography


Similar publications



Contact ORBi